Table of Contents

September 01, 2019; Volume 86, Issue 9
  • From The Editor

  • The Clinical Picture

      • Diabetic dyslipidemia with eruptive xanthoma

        Yu-Chun Hsueh, MD, Chuan-Liang Chou, MD and Ting-I. Lee, MD, PhD
        • Cleveland Clinic Journal of Medicine September 2019, 86 (9) 575-576;
        • DOI: https://doi.org/10.3949/ccjm.86a.18104
        • Off medications for 1 year, her triglyceride level was 10,250 mg/dL, hemoglobin A1c 12.4%.

      • Pseudo-Ludwig angina

        Andrew Tiu, MD and Kamolyut Lapumnuaypol, MD
        • Cleveland Clinic Journal of Medicine September 2019, 86 (9) 577-578;
        • DOI: https://doi.org/10.3949/ccjm.86a.19014
        • A woman on heparin developed a hematoma on the floor of her mouth that threatened to block her airway.

      • Mediastinal granuloma due to histoplasmosis in a patient on infliximab

        Takaaki Kobayashi, MD and Christine Cho, MD
        • Cleveland Clinic Journal of Medicine September 2019, 86 (9) 579-581;
        • DOI: https://doi.org/10.3949/ccjm.86a.18138
        • Immunosuppressive drugs can predispose to invasive fungal infection.

  • 1-Minute Consult

  • Symptoms to Diagnosis

      • A young man with acute chest pain

        Gregory W. Rutecki, MD, Amir Farid, MD, Neil Beri, MD, David Torres-Barba, MD, PhD and Charles Whitcomb, MD
        • Cleveland Clinic Journal of Medicine September 2019, 86 (9) 586-594;
        • DOI: https://doi.org/10.3949/ccjm.86a.19025
        • A young man presents with severe, pressure-like, midsternal, nonradiating pain, rated 10 on a scale of 10.

  • Current Drug Therapy

      • Diabetes management: Beyond hemoglobin A1c

        Vinni Makin, MBBS, MD, FACE and M. Cecilia Lansang, MD, MPH
        • Cleveland Clinic Journal of Medicine September 2019, 86 (9) 595-600;
        • DOI: https://doi.org/10.3949/ccjm.86a.18031
        • Other factors include cardiovascular benefit, weight control, hypoglycemia risk, and cost.

      • ACE inhibitors and ARBs: Managing potassium and renal function

        Tasnim Momoniat, MBCHB, MRCP (UK), Duha Ilyas, MBBS, MRCP (UK) and Sunil Bhandari, MBCHB, FRCP, PhD, M CLIN EDU, FHEA
        • Cleveland Clinic Journal of Medicine September 2019, 86 (9) 601-607;
        • DOI: https://doi.org/10.3949/ccjm.86a.18024
        • Concern about hyperkalemia and a decline in renal function has led to underuse of these drugs.

  • Editorial

      • ACE inhibitor and ARB therapy: Practical recommendations

        Hernan Rincon-Choles, MD, MS
        • Cleveland Clinic Journal of Medicine September 2019, 86 (9) 608-611;
        • DOI: https://doi.org/10.3949/ccjm.86a.19016
        • Inhibitors of the renin-angiotensin-aldosterone system are cornerstones of therapy of cardiovascular disease.

  • Review

      • TOC Icon

        Hemorrhoids: A range of treatments

        Turgut Bora Cengiz, MD and Emre Gorgun, MD, FACS, FASCRS
        • Cleveland Clinic Journal of Medicine September 2019, 86 (9) 612-620;
        • DOI: https://doi.org/10.3949/ccjm.86a.18079
        • Each patient is unique, and with the range of options available, treatment can be individualized.

      • Disparities in cardiovascular care: Past, present, and solutions

        Quentin R. Youmans, MD, Lindsey Hastings-Spaine, MD, Oluseyi Princewill, MD, MPH, Titilayo Shobayo, BS and Ike S. Okwuosa, MD
        • Cleveland Clinic Journal of Medicine September 2019, 86 (9) 621-632;
        • DOI: https://doi.org/10.3949/ccjm.86a.18088
        • Cardiovascular disease makes no distinction in race, sex, age, or socioeconomic status, and neither should clinicians.